HK Stock Market Move | MiniMax listing triggers explosion in the application of artificial intelligence, Xunfei Medical (02506) rises over 20%, leading the AI medical sector.

date
16:11 09/01/2026
avatar
GMT Eight
Xunfei Medical Technology (02506) saw its final trading surge expand to 25%. By the closing bell, the stock had increased by 20.58% to 97.55 Hong Kong dollars, with a trading volume of 190 million Hong Kong dollars.
Xunfei Health (02506) rose as much as 25% in the afternoon, closing with a gain of 20.58% at HK$97.55, with a turnover of HK$190 million. On the news front, the listing of domestic large-scale model enterprise MiniMax soared more than 100% on its first day, igniting the application of artificial intelligence. It is worth mentioning that there has been a recent surge in AI applications in the field of healthcare. On January 8, OpenAI launched the ChatGPT Health feature, which can answer health questions, connect to smart devices, and plan diets and exercises, similar to "Ant Doctor" and "Xunfei Xiaoyi". It is reported that as of November 2025, Xunfei Xiaoyi has completed over 160 million AI health consultations and has exceeded 26 million downloads. Northeast believes that the layout of large models in the medical field has been further strengthened, becoming one of the key focus areas, combined with policy support, AI healthcare is expected to further develop. Southwest points out that under the background of tightening local finances and medical insurance control costs, traditional medical IT investment is under pressure. However, it is clearly stated by the National Health Commission and other departments that increasing investment in AI to improve grassroots diagnosis and treatment and optimize the allocation of medical resources is the direction of incremental investment. From the "14th Five-Year Plan" for national health informationization to various AI application guidelines, the policy support continues to strengthen. Xunfei Health, as the AI medical company with the widest coverage in the industry, is the main target to undertake policy dividends and national projects.